+67.6%
MRNA vs ALHC
-61.4%
+129.0%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ALHC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.9% | -1.6% | -3.3% |
| 7D | -12.1% | +0.3% | -12.4% | -12.2% |
| 30D | -1.3% | -10.6% | +9.3% | -0.5% |
| 3M | +250.9% | -45.3% | +296.3% | +264.9% |
| 6M | +343.0% | -59.7% | +402.7% | +374.1% |
| YTD | +657.4% | -62.7% | +720.2% | +713.5% |
| 1Y | +794.9% | -56.1% | +851.0% | +848.9% |
| 3Y | +218.1% | +21.3% | +196.9% | +186.4% |
| 5Y | -3.4% | -66.0% | +62.6% | -16.5% |
| All | +67.6% | -61.4% | +129.0% | +31.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ALHC.
Daily Out/Under-Performance
Portfolio return minus ALHC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling